MS-DRG 918Medical
Poisoning and Toxic Effects of Drugs without MCC
Major Diagnostic Category 21·Grouped by diagnosis·FY 2027
MS-DRG 918 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 21 (MDC 21) without a significant Complication or Comorbidity. It maps to 1,499 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 0.8720 with a geometric mean length of stay of 2.4 days and an arithmetic mean of 3.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 0.8720 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 2.4 days (used for transfer payments)
- Average stay:
- 3.3 days (arithmetic mean)
- Post-acute transfer policy:
- Yes (early transfers can be paid less)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
| DRG | Title | Relative weight | Mean stay |
|---|---|---|---|
| 917 | Poisoning and Toxic Effects of Drugs with MCC | 1.5700 | 3.7 days |
| 918 | Poisoning and Toxic Effects of Drugs without MCC (this page) | 0.8720 | 2.4 days |
Diagnosis codes (1,499)
As the principal diagnosis, these ICD-10-CM codes can group to DRG 918. 100% of the codes listed are billable.
- M1A.10X0Lead-induced chronic gout, unspecified site, without tophus (tophi)
- M1A.10X1Lead-induced chronic gout, unspecified site, with tophus (tophi)
- M1A.1110Lead-induced chronic gout, right shoulder, without tophus (tophi)
- M1A.1111Lead-induced chronic gout, right shoulder, with tophus (tophi)
- M1A.1120Lead-induced chronic gout, left shoulder, without tophus (tophi)
- M1A.1121Lead-induced chronic gout, left shoulder, with tophus (tophi)
- M1A.1190Lead-induced chronic gout, unspecified shoulder, without tophus (tophi)
- M1A.1191Lead-induced chronic gout, unspecified shoulder, with tophus (tophi)
- M1A.1210Lead-induced chronic gout, right elbow, without tophus (tophi)
- M1A.1211Lead-induced chronic gout, right elbow, with tophus (tophi)
- M1A.1220Lead-induced chronic gout, left elbow, without tophus (tophi)
- M1A.1221Lead-induced chronic gout, left elbow, with tophus (tophi)
- M1A.1290Lead-induced chronic gout, unspecified elbow, without tophus (tophi)
- M1A.1291Lead-induced chronic gout, unspecified elbow, with tophus (tophi)
- M1A.1310Lead-induced chronic gout, right wrist, without tophus (tophi)
- M1A.1311Lead-induced chronic gout, right wrist, with tophus (tophi)
- M1A.1320Lead-induced chronic gout, left wrist, without tophus (tophi)
- M1A.1321Lead-induced chronic gout, left wrist, with tophus (tophi)
- M1A.1390Lead-induced chronic gout, unspecified wrist, without tophus (tophi)
- M1A.1391Lead-induced chronic gout, unspecified wrist, with tophus (tophi)
- M1A.1410Lead-induced chronic gout, right hand, without tophus (tophi)
- M1A.1411Lead-induced chronic gout, right hand, with tophus (tophi)
- M1A.1420Lead-induced chronic gout, left hand, without tophus (tophi)
- M1A.1421Lead-induced chronic gout, left hand, with tophus (tophi)
- M1A.1490Lead-induced chronic gout, unspecified hand, without tophus (tophi)
- M1A.1491Lead-induced chronic gout, unspecified hand, with tophus (tophi)
- M1A.1510Lead-induced chronic gout, right hip, without tophus (tophi)
- M1A.1511Lead-induced chronic gout, right hip, with tophus (tophi)
- M1A.1520Lead-induced chronic gout, left hip, without tophus (tophi)
- M1A.1521Lead-induced chronic gout, left hip, with tophus (tophi)
- M1A.1590Lead-induced chronic gout, unspecified hip, without tophus (tophi)
- M1A.1591Lead-induced chronic gout, unspecified hip, with tophus (tophi)
- M1A.1610Lead-induced chronic gout, right knee, without tophus (tophi)
- M1A.1611Lead-induced chronic gout, right knee, with tophus (tophi)
- M1A.1620Lead-induced chronic gout, left knee, without tophus (tophi)
- M1A.1621Lead-induced chronic gout, left knee, with tophus (tophi)
- M1A.1690Lead-induced chronic gout, unspecified knee, without tophus (tophi)
- M1A.1691Lead-induced chronic gout, unspecified knee, with tophus (tophi)
- M1A.1710Lead-induced chronic gout, right ankle and foot, without tophus (tophi)
- M1A.1711Lead-induced chronic gout, right ankle and foot, with tophus (tophi)
- M1A.1720Lead-induced chronic gout, left ankle and foot, without tophus (tophi)
- M1A.1721Lead-induced chronic gout, left ankle and foot, with tophus (tophi)
- M1A.1790Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi)
- M1A.1791Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi)
- M1A.18X0Lead-induced chronic gout, vertebrae, without tophus (tophi)
- M1A.18X1Lead-induced chronic gout, vertebrae, with tophus (tophi)
- M1A.19X0Lead-induced chronic gout, multiple sites, without tophus (tophi)
- M1A.19X1Lead-induced chronic gout, multiple sites, with tophus (tophi)
- T36.0X1APoisoning by penicillins, accidental (unintentional), initial encounter
- T36.0X2APoisoning by penicillins, intentional self-harm, initial encounter
- T36.0X3APoisoning by penicillins, assault, initial encounter
- T36.0X4APoisoning by penicillins, undetermined, initial encounter
- T36.0X5AAdverse effect of penicillins, initial encounter
- T36.1X1APoisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), initial encounter
- T36.1X2APoisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter
- T36.1X3APoisoning by cephalosporins and other beta-lactam antibiotics, assault, initial encounter
- T36.1X4APoisoning by cephalosporins and other beta-lactam antibiotics, undetermined, initial encounter
- T36.1X5AAdverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.2X1APoisoning by chloramphenicol group, accidental (unintentional), initial encounter
- T36.2X2APoisoning by chloramphenicol group, intentional self-harm, initial encounter
- T36.2X3APoisoning by chloramphenicol group, assault, initial encounter
- T36.2X4APoisoning by chloramphenicol group, undetermined, initial encounter
- T36.2X5AAdverse effect of chloramphenicol group, initial encounter
- T36.3X1APoisoning by macrolides, accidental (unintentional), initial encounter
- T36.3X2APoisoning by macrolides, intentional self-harm, initial encounter
- T36.3X3APoisoning by macrolides, assault, initial encounter
- T36.3X4APoisoning by macrolides, undetermined, initial encounter
- T36.3X5AAdverse effect of macrolides, initial encounter
- T36.4X1APoisoning by tetracyclines, accidental (unintentional), initial encounter
- T36.4X2APoisoning by tetracyclines, intentional self-harm, initial encounter
- T36.4X3APoisoning by tetracyclines, assault, initial encounter
- T36.4X4APoisoning by tetracyclines, undetermined, initial encounter
- T36.4X5AAdverse effect of tetracyclines, initial encounter
- T36.5X1APoisoning by aminoglycosides, accidental (unintentional), initial encounter
- T36.5X2APoisoning by aminoglycosides, intentional self-harm, initial encounter
- T36.5X3APoisoning by aminoglycosides, assault, initial encounter
- T36.5X4APoisoning by aminoglycosides, undetermined, initial encounter
- T36.5X5AAdverse effect of aminoglycosides, initial encounter
- T36.6X1APoisoning by rifampicins, accidental (unintentional), initial encounter
- T36.6X2APoisoning by rifampicins, intentional self-harm, initial encounter
- T36.6X3APoisoning by rifampicins, assault, initial encounter
- T36.6X4APoisoning by rifampicins, undetermined, initial encounter
- T36.6X5AAdverse effect of rifampicins, initial encounter
- T36.7X1APoisoning by antifungal antibiotics, systemically used, accidental (unintentional), initial encounter
- T36.7X2APoisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter
- T36.7X3APoisoning by antifungal antibiotics, systemically used, assault, initial encounter
- T36.7X4APoisoning by antifungal antibiotics, systemically used, undetermined, initial encounter
- T36.7X5AAdverse effect of antifungal antibiotics, systemically used, initial encounter
- T36.8X1APoisoning by other systemic antibiotics, accidental (unintentional), initial encounter
- T36.8X2APoisoning by other systemic antibiotics, intentional self-harm, initial encounter
- T36.8X3APoisoning by other systemic antibiotics, assault, initial encounter
- T36.8X4APoisoning by other systemic antibiotics, undetermined, initial encounter
- T36.8X5AAdverse effect of other systemic antibiotics, initial encounter
- T36.91XAPoisoning by unspecified systemic antibiotic, accidental (unintentional), initial encounter
- T36.92XAPoisoning by unspecified systemic antibiotic, intentional self-harm, initial encounter
- T36.93XAPoisoning by unspecified systemic antibiotic, assault, initial encounter
- T36.94XAPoisoning by unspecified systemic antibiotic, undetermined, initial encounter
- T36.95XAAdverse effect of unspecified systemic antibiotic, initial encounter
- T36.AX1APoisoning by fluoroquinolone antibiotics, accidental (unintentional), initial encounter
- T36.AX2APoisoning by fluoroquinolone antibiotics, intentional self-harm, initial encounter
- T36.AX3APoisoning by fluoroquinolone antibiotics, assault, initial encounter
- T36.AX4APoisoning by fluoroquinolone antibiotics, undetermined, initial encounter
- T36.AX5AAdverse effect of fluoroquinolone antibiotics, initial encounter
- T37.0X1APoisoning by sulfonamides, accidental (unintentional), initial encounter
- T37.0X2APoisoning by sulfonamides, intentional self-harm, initial encounter
- T37.0X3APoisoning by sulfonamides, assault, initial encounter
- T37.0X4APoisoning by sulfonamides, undetermined, initial encounter
- T37.0X5AAdverse effect of sulfonamides, initial encounter
- T37.1X1APoisoning by antimycobacterial drugs, accidental (unintentional), initial encounter
- T37.1X2APoisoning by antimycobacterial drugs, intentional self-harm, initial encounter
- T37.1X3APoisoning by antimycobacterial drugs, assault, initial encounter
- T37.1X4APoisoning by antimycobacterial drugs, undetermined, initial encounter
- T37.1X5AAdverse effect of antimycobacterial drugs, initial encounter
- T37.2X1APoisoning by antimalarials and drugs acting on other blood protozoa, accidental (unintentional), initial encounter
- T37.2X2APoisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm, initial encounter
- T37.2X3APoisoning by antimalarials and drugs acting on other blood protozoa, assault, initial encounter
- T37.2X4APoisoning by antimalarials and drugs acting on other blood protozoa, undetermined, initial encounter
- T37.2X5AAdverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
- T37.3X1APoisoning by other antiprotozoal drugs, accidental (unintentional), initial encounter
- T37.3X2APoisoning by other antiprotozoal drugs, intentional self-harm, initial encounter
- T37.3X3APoisoning by other antiprotozoal drugs, assault, initial encounter
- T37.3X4APoisoning by other antiprotozoal drugs, undetermined, initial encounter
- T37.3X5AAdverse effect of other antiprotozoal drugs, initial encounter
- T37.4X1APoisoning by anthelminthics, accidental (unintentional), initial encounter
- T37.4X2APoisoning by anthelminthics, intentional self-harm, initial encounter
- T37.4X3APoisoning by anthelminthics, assault, initial encounter
- T37.4X4APoisoning by anthelminthics, undetermined, initial encounter
- T37.4X5AAdverse effect of anthelminthics, initial encounter
- T37.5X1APoisoning by antiviral drugs, accidental (unintentional), initial encounter
- T37.5X2APoisoning by antiviral drugs, intentional self-harm, initial encounter
- T37.5X3APoisoning by antiviral drugs, assault, initial encounter
- T37.5X4APoisoning by antiviral drugs, undetermined, initial encounter
- T37.5X5AAdverse effect of antiviral drugs, initial encounter
- T37.8X1APoisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter
- T37.8X2APoisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, initial encounter
- T37.8X3APoisoning by other specified systemic anti-infectives and antiparasitics, assault, initial encounter
- T37.8X4APoisoning by other specified systemic anti-infectives and antiparasitics, undetermined, initial encounter
- T37.8X5AAdverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
- T37.91XAPoisoning by unspecified systemic anti-infective and antiparasitics, accidental (unintentional), initial encounter
- T37.92XAPoisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm, initial encounter
- T37.93XAPoisoning by unspecified systemic anti-infective and antiparasitics, assault, initial encounter
- T37.94XAPoisoning by unspecified systemic anti-infective and antiparasitics, undetermined, initial encounter
- T37.95XAAdverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
- T38.0X1APoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter
- T38.0X2APoisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter
- T38.0X3APoisoning by glucocorticoids and synthetic analogues, assault, initial encounter
- T38.0X4APoisoning by glucocorticoids and synthetic analogues, undetermined, initial encounter
- T38.0X5AAdverse effect of glucocorticoids and synthetic analogues, initial encounter
- T38.1X1APoisoning by thyroid hormones and substitutes, accidental (unintentional), initial encounter
- T38.1X2APoisoning by thyroid hormones and substitutes, intentional self-harm, initial encounter
- T38.1X3APoisoning by thyroid hormones and substitutes, assault, initial encounter
- T38.1X4APoisoning by thyroid hormones and substitutes, undetermined, initial encounter
- T38.1X5AAdverse effect of thyroid hormones and substitutes, initial encounter
- T38.2X1APoisoning by antithyroid drugs, accidental (unintentional), initial encounter
- T38.2X2APoisoning by antithyroid drugs, intentional self-harm, initial encounter
- T38.2X3APoisoning by antithyroid drugs, assault, initial encounter
- T38.2X4APoisoning by antithyroid drugs, undetermined, initial encounter
- T38.2X5AAdverse effect of antithyroid drugs, initial encounter
- T38.3X1APoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional), initial encounter
- T38.3X2APoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, initial encounter
- T38.3X3APoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, assault, initial encounter
- T38.3X4APoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, undetermined, initial encounter
- T38.3X5AAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
- T38.4X1APoisoning by oral contraceptives, accidental (unintentional), initial encounter
- T38.4X2APoisoning by oral contraceptives, intentional self-harm, initial encounter
- T38.4X3APoisoning by oral contraceptives, assault, initial encounter
- T38.4X4APoisoning by oral contraceptives, undetermined, initial encounter
- T38.4X5AAdverse effect of oral contraceptives, initial encounter
- T38.5X1APoisoning by other estrogens and progestogens, accidental (unintentional), initial encounter
- T38.5X2APoisoning by other estrogens and progestogens, intentional self-harm, initial encounter
- T38.5X3APoisoning by other estrogens and progestogens, assault, initial encounter
- T38.5X4APoisoning by other estrogens and progestogens, undetermined, initial encounter
- T38.5X5AAdverse effect of other estrogens and progestogens, initial encounter
- T38.6X1APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter
- T38.6X2APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, initial encounter
- T38.6X3APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, assault, initial encounter
- T38.6X4APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, undetermined, initial encounter
- T38.6X5AAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
- T38.7X1APoisoning by androgens and anabolic congeners, accidental (unintentional), initial encounter
- T38.7X2APoisoning by androgens and anabolic congeners, intentional self-harm, initial encounter
- T38.7X3APoisoning by androgens and anabolic congeners, assault, initial encounter
- T38.7X4APoisoning by androgens and anabolic congeners, undetermined, initial encounter
- T38.7X5AAdverse effect of androgens and anabolic congeners, initial encounter
- T38.801APoisoning by unspecified hormones and synthetic substitutes, accidental (unintentional), initial encounter
- T38.802APoisoning by unspecified hormones and synthetic substitutes, intentional self-harm, initial encounter
- T38.803APoisoning by unspecified hormones and synthetic substitutes, assault, initial encounter
- T38.804APoisoning by unspecified hormones and synthetic substitutes, undetermined, initial encounter
- T38.805AAdverse effect of unspecified hormones and synthetic substitutes, initial encounter
- T38.811APoisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), initial encounter
- T38.812APoisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, initial encounter
- T38.813APoisoning by anterior pituitary [adenohypophyseal] hormones, assault, initial encounter
- T38.814APoisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, initial encounter
- T38.815AAdverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
- T38.891APoisoning by other hormones and synthetic substitutes, accidental (unintentional), initial encounter
- T38.892APoisoning by other hormones and synthetic substitutes, intentional self-harm, initial encounter
- T38.893APoisoning by other hormones and synthetic substitutes, assault, initial encounter
- T38.894APoisoning by other hormones and synthetic substitutes, undetermined, initial encounter
- T38.895AAdverse effect of other hormones and synthetic substitutes, initial encounter
- T38.901APoisoning by unspecified hormone antagonists, accidental (unintentional), initial encounter
- T38.902APoisoning by unspecified hormone antagonists, intentional self-harm, initial encounter
- T38.903APoisoning by unspecified hormone antagonists, assault, initial encounter
- T38.904APoisoning by unspecified hormone antagonists, undetermined, initial encounter
- T38.905AAdverse effect of unspecified hormone antagonists, initial encounter
- T38.991APoisoning by other hormone antagonists, accidental (unintentional), initial encounter
- T38.992APoisoning by other hormone antagonists, intentional self-harm, initial encounter
- T38.993APoisoning by other hormone antagonists, assault, initial encounter
- T38.994APoisoning by other hormone antagonists, undetermined, initial encounter
- T38.995AAdverse effect of other hormone antagonists, initial encounter
- T39.011APoisoning by aspirin, accidental (unintentional), initial encounter
- T39.012APoisoning by aspirin, intentional self-harm, initial encounter
- T39.013APoisoning by aspirin, assault, initial encounter
- T39.014APoisoning by aspirin, undetermined, initial encounter
- T39.015AAdverse effect of aspirin, initial encounter
- T39.091APoisoning by salicylates, accidental (unintentional), initial encounter
- T39.092APoisoning by salicylates, intentional self-harm, initial encounter
- T39.093APoisoning by salicylates, assault, initial encounter
- T39.094APoisoning by salicylates, undetermined, initial encounter
- T39.095AAdverse effect of salicylates, initial encounter
- T39.1X1APoisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
- T39.1X2APoisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
- T39.1X3APoisoning by 4-Aminophenol derivatives, assault, initial encounter
- T39.1X4APoisoning by 4-Aminophenol derivatives, undetermined, initial encounter
- T39.1X5AAdverse effect of 4-Aminophenol derivatives, initial encounter
- T39.2X1APoisoning by pyrazolone derivatives, accidental (unintentional), initial encounter
- T39.2X2APoisoning by pyrazolone derivatives, intentional self-harm, initial encounter
- T39.2X3APoisoning by pyrazolone derivatives, assault, initial encounter
- T39.2X4APoisoning by pyrazolone derivatives, undetermined, initial encounter
- T39.2X5AAdverse effect of pyrazolone derivatives, initial encounter
- T39.311APoisoning by propionic acid derivatives, accidental (unintentional), initial encounter
- T39.312APoisoning by propionic acid derivatives, intentional self-harm, initial encounter
- T39.313APoisoning by propionic acid derivatives, assault, initial encounter
- T39.314APoisoning by propionic acid derivatives, undetermined, initial encounter
- T39.315AAdverse effect of propionic acid derivatives, initial encounter
- T39.391APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter
- T39.392APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter
- T39.393APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter
- T39.394APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter
- T39.395AAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
- T39.4X1APoisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter
- T39.4X2APoisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter
- T39.4X3APoisoning by antirheumatics, not elsewhere classified, assault, initial encounter
- T39.4X4APoisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter
- T39.4X5AAdverse effect of antirheumatics, not elsewhere classified, initial encounter
- T39.8X1APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter
- T39.8X2APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter
- T39.8X3APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter
- T39.8X4APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter
- T39.8X5AAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
- T39.91XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter
- T39.92XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter
- T39.93XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter
- T39.94XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter
- T39.95XAAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T40.0X1APoisoning by opium, accidental (unintentional), initial encounter
- T40.0X2APoisoning by opium, intentional self-harm, initial encounter
- T40.0X3APoisoning by opium, assault, initial encounter
- T40.0X4APoisoning by opium, undetermined, initial encounter
- T40.0X5AAdverse effect of opium, initial encounter
- T40.1X1APoisoning by heroin, accidental (unintentional), initial encounter
- T40.1X2APoisoning by heroin, intentional self-harm, initial encounter
- T40.1X3APoisoning by heroin, assault, initial encounter
- T40.1X4APoisoning by heroin, undetermined, initial encounter
- T40.2X1APoisoning by other opioids, accidental (unintentional), initial encounter
- T40.2X2APoisoning by other opioids, intentional self-harm, initial encounter
- T40.2X3APoisoning by other opioids, assault, initial encounter
- T40.2X4APoisoning by other opioids, undetermined, initial encounter
- T40.2X5AAdverse effect of other opioids, initial encounter
- T40.3X1APoisoning by methadone, accidental (unintentional), initial encounter
- T40.3X2APoisoning by methadone, intentional self-harm, initial encounter
- T40.3X3APoisoning by methadone, assault, initial encounter
- T40.3X4APoisoning by methadone, undetermined, initial encounter
- T40.3X5AAdverse effect of methadone, initial encounter
- T40.411APoisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter
- T40.412APoisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter
- T40.413APoisoning by fentanyl or fentanyl analogs, assault, initial encounter
- T40.414APoisoning by fentanyl or fentanyl analogs, undetermined, initial encounter
- T40.415AAdverse effect of fentanyl or fentanyl analogs, initial encounter
- T40.421APoisoning by tramadol, accidental (unintentional), initial encounter
- T40.422APoisoning by tramadol, intentional self-harm, initial encounter
- T40.423APoisoning by tramadol, assault, initial encounter
- T40.424APoisoning by tramadol, undetermined, initial encounter
- T40.425AAdverse effect of tramadol, initial encounter
- T40.491APoisoning by other synthetic narcotics, accidental (unintentional), initial encounter
- T40.492APoisoning by other synthetic narcotics, intentional self-harm, initial encounter
- T40.493APoisoning by other synthetic narcotics, assault, initial encounter
- T40.494APoisoning by other synthetic narcotics, undetermined, initial encounter
- T40.495AAdverse effect of other synthetic narcotics, initial encounter
- T40.5X1APoisoning by cocaine, accidental (unintentional), initial encounter
- T40.5X2APoisoning by cocaine, intentional self-harm, initial encounter
- T40.5X3APoisoning by cocaine, assault, initial encounter
- T40.5X4APoisoning by cocaine, undetermined, initial encounter
- T40.5X5AAdverse effect of cocaine, initial encounter
- T40.601APoisoning by unspecified narcotics, accidental (unintentional), initial encounter
- T40.602APoisoning by unspecified narcotics, intentional self-harm, initial encounter
- T40.603APoisoning by unspecified narcotics, assault, initial encounter
- T40.604APoisoning by unspecified narcotics, undetermined, initial encounter
- T40.605AAdverse effect of unspecified narcotics, initial encounter
- T40.691APoisoning by other narcotics, accidental (unintentional), initial encounter
- T40.692APoisoning by other narcotics, intentional self-harm, initial encounter
- T40.693APoisoning by other narcotics, assault, initial encounter
- T40.694APoisoning by other narcotics, undetermined, initial encounter
- T40.695AAdverse effect of other narcotics, initial encounter
- T40.711APoisoning by cannabis, accidental (unintentional), initial encounter
- T40.712APoisoning by cannabis, intentional self-harm, initial encounter
- T40.713APoisoning by cannabis, assault, initial encounter
- T40.714APoisoning by cannabis, undetermined, initial encounter
- T40.715AAdverse effect of cannabis, initial encounter
- T40.721APoisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
- T40.722APoisoning by synthetic cannabinoids, intentional self-harm, initial encounter
- T40.723APoisoning by synthetic cannabinoids, assault, initial encounter
- T40.724APoisoning by synthetic cannabinoids, undetermined, initial encounter
- T40.725AAdverse effect of synthetic cannabinoids, initial encounter
- T40.8X1APoisoning by lysergide [LSD], accidental (unintentional), initial encounter
- T40.8X2APoisoning by lysergide [LSD], intentional self-harm, initial encounter
- T40.8X3APoisoning by lysergide [LSD], assault, initial encounter
- T40.8X4APoisoning by lysergide [LSD], undetermined, initial encounter
- T40.901APoisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
- T40.902APoisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
- T40.903APoisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
- T40.904APoisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
- T40.905AAdverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
- T40.991APoisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
- T40.992APoisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
- T40.993APoisoning by other psychodysleptics [hallucinogens], assault, initial encounter
- T40.994APoisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
- T40.995AAdverse effect of other psychodysleptics [hallucinogens], initial encounter
- T41.0X1APoisoning by inhaled anesthetics, accidental (unintentional), initial encounter
- T41.0X2APoisoning by inhaled anesthetics, intentional self-harm, initial encounter
- T41.0X3APoisoning by inhaled anesthetics, assault, initial encounter
- T41.0X4APoisoning by inhaled anesthetics, undetermined, initial encounter
- T41.0X5AAdverse effect of inhaled anesthetics, initial encounter
- T41.1X1APoisoning by intravenous anesthetics, accidental (unintentional), initial encounter
- T41.1X2APoisoning by intravenous anesthetics, intentional self-harm, initial encounter
- T41.1X3APoisoning by intravenous anesthetics, assault, initial encounter
- T41.1X4APoisoning by intravenous anesthetics, undetermined, initial encounter
- T41.1X5AAdverse effect of intravenous anesthetics, initial encounter
- T41.201APoisoning by unspecified general anesthetics, accidental (unintentional), initial encounter
- T41.202APoisoning by unspecified general anesthetics, intentional self-harm, initial encounter
- T41.203APoisoning by unspecified general anesthetics, assault, initial encounter
- T41.204APoisoning by unspecified general anesthetics, undetermined, initial encounter
- T41.205AAdverse effect of unspecified general anesthetics, initial encounter
- T41.291APoisoning by other general anesthetics, accidental (unintentional), initial encounter
- T41.292APoisoning by other general anesthetics, intentional self-harm, initial encounter
- T41.293APoisoning by other general anesthetics, assault, initial encounter
- T41.294APoisoning by other general anesthetics, undetermined, initial encounter
- T41.295AAdverse effect of other general anesthetics, initial encounter
- T41.3X1APoisoning by local anesthetics, accidental (unintentional), initial encounter
- T41.3X2APoisoning by local anesthetics, intentional self-harm, initial encounter
- T41.3X3APoisoning by local anesthetics, assault, initial encounter
- T41.3X4APoisoning by local anesthetics, undetermined, initial encounter
- T41.3X5AAdverse effect of local anesthetics, initial encounter
- T41.41XAPoisoning by unspecified anesthetic, accidental (unintentional), initial encounter
- T41.42XAPoisoning by unspecified anesthetic, intentional self-harm, initial encounter
- T41.43XAPoisoning by unspecified anesthetic, assault, initial encounter
- T41.44XAPoisoning by unspecified anesthetic, undetermined, initial encounter
- T41.45XAAdverse effect of unspecified anesthetic, initial encounter
- T41.5X1APoisoning by therapeutic gases, accidental (unintentional), initial encounter
- T41.5X2APoisoning by therapeutic gases, intentional self-harm, initial encounter
- T41.5X3APoisoning by therapeutic gases, assault, initial encounter
- T41.5X4APoisoning by therapeutic gases, undetermined, initial encounter
- T41.5X5AAdverse effect of therapeutic gases, initial encounter
- T42.0X1APoisoning by hydantoin derivatives, accidental (unintentional), initial encounter
- T42.0X2APoisoning by hydantoin derivatives, intentional self-harm, initial encounter
- T42.0X3APoisoning by hydantoin derivatives, assault, initial encounter
- T42.0X4APoisoning by hydantoin derivatives, undetermined, initial encounter
- T42.0X5AAdverse effect of hydantoin derivatives, initial encounter
- T42.1X1APoisoning by iminostilbenes, accidental (unintentional), initial encounter
- T42.1X2APoisoning by iminostilbenes, intentional self-harm, initial encounter
- T42.1X3APoisoning by iminostilbenes, assault, initial encounter
- T42.1X4APoisoning by iminostilbenes, undetermined, initial encounter
- T42.1X5AAdverse effect of iminostilbenes, initial encounter
- T42.2X1APoisoning by succinimides and oxazolidinediones, accidental (unintentional), initial encounter
- T42.2X2APoisoning by succinimides and oxazolidinediones, intentional self-harm, initial encounter
- T42.2X3APoisoning by succinimides and oxazolidinediones, assault, initial encounter
- T42.2X4APoisoning by succinimides and oxazolidinediones, undetermined, initial encounter
- T42.2X5AAdverse effect of succinimides and oxazolidinediones, initial encounter
- T42.3X1APoisoning by barbiturates, accidental (unintentional), initial encounter
- T42.3X2APoisoning by barbiturates, intentional self-harm, initial encounter
- T42.3X3APoisoning by barbiturates, assault, initial encounter
- T42.3X4APoisoning by barbiturates, undetermined, initial encounter
- T42.3X5AAdverse effect of barbiturates, initial encounter
- T42.4X1APoisoning by benzodiazepines, accidental (unintentional), initial encounter
- T42.4X2APoisoning by benzodiazepines, intentional self-harm, initial encounter
- T42.4X3APoisoning by benzodiazepines, assault, initial encounter
- T42.4X4APoisoning by benzodiazepines, undetermined, initial encounter
- T42.4X5AAdverse effect of benzodiazepines, initial encounter
- T42.5X1APoisoning by mixed antiepileptics, accidental (unintentional), initial encounter
- T42.5X2APoisoning by mixed antiepileptics, intentional self-harm, initial encounter
- T42.5X3APoisoning by mixed antiepileptics, assault, initial encounter
- T42.5X4APoisoning by mixed antiepileptics, undetermined, initial encounter
- T42.5X5AAdverse effect of mixed antiepileptics, initial encounter
- T42.6X1APoisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
- T42.6X2APoisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
- T42.6X3APoisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter
- T42.6X4APoisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
- T42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.71XAPoisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
- T42.72XAPoisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
- T42.73XAPoisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter
- T42.74XAPoisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
- T42.75XAAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.8X1APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter
- T42.8X2APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter
- T42.8X3APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter
- T42.8X4APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter
- T42.8X5AAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
- T43.011APoisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
- T43.012APoisoning by tricyclic antidepressants, intentional self-harm, initial encounter
- T43.013APoisoning by tricyclic antidepressants, assault, initial encounter
- T43.014APoisoning by tricyclic antidepressants, undetermined, initial encounter
- T43.015AAdverse effect of tricyclic antidepressants, initial encounter
- T43.021APoisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
- T43.022APoisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
- T43.023APoisoning by tetracyclic antidepressants, assault, initial encounter
- T43.024APoisoning by tetracyclic antidepressants, undetermined, initial encounter
- T43.025AAdverse effect of tetracyclic antidepressants, initial encounter
- T43.1X1APoisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
- T43.1X2APoisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
- T43.1X3APoisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
- T43.1X4APoisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
- T43.1X5AAdverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.201APoisoning by unspecified antidepressants, accidental (unintentional), initial encounter
- T43.202APoisoning by unspecified antidepressants, intentional self-harm, initial encounter
- T43.203APoisoning by unspecified antidepressants, assault, initial encounter
- T43.204APoisoning by unspecified antidepressants, undetermined, initial encounter
- T43.205AAdverse effect of unspecified antidepressants, initial encounter
- T43.211APoisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
- T43.212APoisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
- T43.213APoisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
- T43.214APoisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
- T43.215AAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.221APoisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
- T43.222APoisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
- T43.223APoisoning by selective serotonin reuptake inhibitors, assault, initial encounter
- T43.224APoisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
- T43.225AAdverse effect of selective serotonin reuptake inhibitors, initial encounter
- T43.291APoisoning by other antidepressants, accidental (unintentional), initial encounter
- T43.292APoisoning by other antidepressants, intentional self-harm, initial encounter
- T43.293APoisoning by other antidepressants, assault, initial encounter
- T43.294APoisoning by other antidepressants, undetermined, initial encounter
- T43.295AAdverse effect of other antidepressants, initial encounter
- T43.3X1APoisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.3X2APoisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.3X3APoisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
- T43.3X4APoisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
- T43.3X5AAdverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.4X1APoisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
- T43.4X2APoisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
- T43.4X3APoisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
- T43.4X4APoisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
- T43.4X5AAdverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.501APoisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.502APoisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.503APoisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
- T43.504APoisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
- T43.505AAdverse effect of unspecified antipsychotics and neuroleptics, initial encounter
- T43.591APoisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.592APoisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.593APoisoning by other antipsychotics and neuroleptics, assault, initial encounter
- T43.594APoisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
- T43.595AAdverse effect of other antipsychotics and neuroleptics, initial encounter
- T43.601APoisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
- T43.602APoisoning by unspecified psychostimulants, intentional self-harm, initial encounter
- T43.603APoisoning by unspecified psychostimulants, assault, initial encounter
- T43.604APoisoning by unspecified psychostimulants, undetermined, initial encounter
- T43.605AAdverse effect of unspecified psychostimulants, initial encounter
- T43.611APoisoning by caffeine, accidental (unintentional), initial encounter
- T43.612APoisoning by caffeine, intentional self-harm, initial encounter
- T43.613APoisoning by caffeine, assault, initial encounter
- T43.614APoisoning by caffeine, undetermined, initial encounter
- T43.615AAdverse effect of caffeine, initial encounter
- T43.621APoisoning by amphetamines, accidental (unintentional), initial encounter
- T43.622APoisoning by amphetamines, intentional self-harm, initial encounter
- T43.623APoisoning by amphetamines, assault, initial encounter
- T43.624APoisoning by amphetamines, undetermined, initial encounter
- T43.625AAdverse effect of amphetamines, initial encounter
- T43.631APoisoning by methylphenidate, accidental (unintentional), initial encounter
- T43.632APoisoning by methylphenidate, intentional self-harm, initial encounter
- T43.633APoisoning by methylphenidate, assault, initial encounter
- T43.634APoisoning by methylphenidate, undetermined, initial encounter
- T43.635AAdverse effect of methylphenidate, initial encounter
- T43.641APoisoning by ecstasy, accidental (unintentional), initial encounter
- T43.642APoisoning by ecstasy, intentional self-harm, initial encounter
- T43.643APoisoning by ecstasy, assault, initial encounter
- T43.644APoisoning by ecstasy, undetermined, initial encounter
- T43.651APoisoning by methamphetamines accidental (unintentional), initial encounter
- T43.652APoisoning by methamphetamines intentional self-harm, initial encounter
- T43.653APoisoning by methamphetamines, assault, initial encounter
- T43.654APoisoning by methamphetamines, undetermined, initial encounter
- T43.655AAdverse effect of methamphetamines, initial encounter
- T43.691APoisoning by other psychostimulants, accidental (unintentional), initial encounter
- T43.692APoisoning by other psychostimulants, intentional self-harm, initial encounter
- T43.693APoisoning by other psychostimulants, assault, initial encounter
- T43.694APoisoning by other psychostimulants, undetermined, initial encounter
- T43.695AAdverse effect of other psychostimulants, initial encounter
- T43.8X1APoisoning by other psychotropic drugs, accidental (unintentional), initial encounter
- T43.8X2APoisoning by other psychotropic drugs, intentional self-harm, initial encounter
- T43.8X3APoisoning by other psychotropic drugs, assault, initial encounter
- T43.8X4APoisoning by other psychotropic drugs, undetermined, initial encounter
- T43.8X5AAdverse effect of other psychotropic drugs, initial encounter
- T43.91XAPoisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
- T43.92XAPoisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
- T43.93XAPoisoning by unspecified psychotropic drug, assault, initial encounter
- T43.94XAPoisoning by unspecified psychotropic drug, undetermined, initial encounter
- T43.95XAAdverse effect of unspecified psychotropic drug, initial encounter
- T44.0X1APoisoning by anticholinesterase agents, accidental (unintentional), initial encounter
- T44.0X2APoisoning by anticholinesterase agents, intentional self-harm, initial encounter
- T44.0X3APoisoning by anticholinesterase agents, assault, initial encounter
- T44.0X4APoisoning by anticholinesterase agents, undetermined, initial encounter
- T44.0X5AAdverse effect of anticholinesterase agents, initial encounter
- T44.1X1APoisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter
- T44.1X2APoisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter
- T44.1X3APoisoning by other parasympathomimetics [cholinergics], assault, initial encounter
- T44.1X4APoisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter
- T44.1X5AAdverse effect of other parasympathomimetics [cholinergics], initial encounter
- T44.2X1APoisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
- T44.2X2APoisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
- T44.2X3APoisoning by ganglionic blocking drugs, assault, initial encounter
- T44.2X4APoisoning by ganglionic blocking drugs, undetermined, initial encounter
- T44.2X5AAdverse effect of ganglionic blocking drugs, initial encounter
- T44.3X1APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
- T44.3X2APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
- T44.3X3APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
- T44.3X4APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
- T44.3X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
- T44.4X1APoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
- T44.4X2APoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
- T44.4X3APoisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
- T44.4X4APoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
- T44.4X5AAdverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
- T44.5X1APoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
- T44.5X2APoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
- T44.5X3APoisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
- T44.5X4APoisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
- T44.5X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
- T44.6X1APoisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter
- T44.6X2APoisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter
- T44.6X3APoisoning by alpha-adrenoreceptor antagonists, assault, initial encounter
- T44.6X4APoisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter
- T44.6X5AAdverse effect of alpha-adrenoreceptor antagonists, initial encounter
- T44.7X1APoisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter
- T44.7X2APoisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter
- T44.7X3APoisoning by beta-adrenoreceptor antagonists, assault, initial encounter
- T44.7X4APoisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter
- T44.7X5AAdverse effect of beta-adrenoreceptor antagonists, initial encounter
- T44.8X1APoisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter
- T44.8X2APoisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter
- T44.8X3APoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter
- T44.8X4APoisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter
- T44.8X5AAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
- T44.901APoisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
- T44.902APoisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
- T44.903APoisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter
- T44.904APoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter
- T44.905AAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
- T44.991APoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
- T44.992APoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
- T44.993APoisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter
- T44.994APoisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter
- T44.995AAdverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
- T45.0X1APoisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
- T45.0X2APoisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
- T45.0X3APoisoning by antiallergic and antiemetic drugs, assault, initial encounter
- T45.0X4APoisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
- T45.0X5AAdverse effect of antiallergic and antiemetic drugs, initial encounter
- T45.1X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
- T45.1X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
- T45.1X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
- T45.1X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
- T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
- T45.2X1APoisoning by vitamins, accidental (unintentional), initial encounter
- T45.2X2APoisoning by vitamins, intentional self-harm, initial encounter
- T45.2X3APoisoning by vitamins, assault, initial encounter
- T45.2X4APoisoning by vitamins, undetermined, initial encounter
- T45.2X5AAdverse effect of vitamins, initial encounter
- T45.3X1APoisoning by enzymes, accidental (unintentional), initial encounter
- T45.3X2APoisoning by enzymes, intentional self-harm, initial encounter
- T45.3X3APoisoning by enzymes, assault, initial encounter
- T45.3X4APoisoning by enzymes, undetermined, initial encounter
- T45.3X5AAdverse effect of enzymes, initial encounter
- T45.4X1APoisoning by iron and its compounds, accidental (unintentional), initial encounter
- T45.4X2APoisoning by iron and its compounds, intentional self-harm, initial encounter
- T45.4X3APoisoning by iron and its compounds, assault, initial encounter
- T45.4X4APoisoning by iron and its compounds, undetermined, initial encounter
- T45.4X5AAdverse effect of iron and its compounds, initial encounter
- T45.511APoisoning by anticoagulants, accidental (unintentional), initial encounter
- T45.512APoisoning by anticoagulants, intentional self-harm, initial encounter
- T45.513APoisoning by anticoagulants, assault, initial encounter
- T45.514APoisoning by anticoagulants, undetermined, initial encounter
- T45.515AAdverse effect of anticoagulants, initial encounter
- T45.521APoisoning by antithrombotic drugs, accidental (unintentional), initial encounter
- T45.522APoisoning by antithrombotic drugs, intentional self-harm, initial encounter
- T45.523APoisoning by antithrombotic drugs, assault, initial encounter
- T45.524APoisoning by antithrombotic drugs, undetermined, initial encounter
- T45.525AAdverse effect of antithrombotic drugs, initial encounter
- T45.601APoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
- T45.602APoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
- T45.603APoisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
- T45.604APoisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
- T45.605AAdverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
- T45.611APoisoning by thrombolytic drug, accidental (unintentional), initial encounter
- T45.612APoisoning by thrombolytic drug, intentional self-harm, initial encounter
- T45.613APoisoning by thrombolytic drug, assault, initial encounter
- T45.614APoisoning by thrombolytic drug, undetermined, initial encounter
- T45.615AAdverse effect of thrombolytic drugs, initial encounter
- T45.621APoisoning by hemostatic drug, accidental (unintentional), initial encounter
- T45.622APoisoning by hemostatic drug, intentional self-harm, initial encounter
- T45.623APoisoning by hemostatic drug, assault, initial encounter
- T45.624APoisoning by hemostatic drug, undetermined, initial encounter
- T45.625AAdverse effect of hemostatic drug, initial encounter
- T45.691APoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
- T45.692APoisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
- T45.693APoisoning by other fibrinolysis-affecting drugs, assault, initial encounter
- T45.694APoisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
- T45.695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
- T45.7X1APoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
- T45.7X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
- T45.7X3APoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
- T45.7X4APoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
- T45.7X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
- T45.8X1APoisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
- T45.8X2APoisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
- T45.8X3APoisoning by other primarily systemic and hematological agents, assault, initial encounter
- T45.8X4APoisoning by other primarily systemic and hematological agents, undetermined, initial encounter
- T45.8X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
- T45.91XAPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
- T45.92XAPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
- T45.93XAPoisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
- T45.94XAPoisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
- T45.95XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounter
- T45.AX1APoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter
- T45.AX2APoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter
- T45.AX3APoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter
- T45.AX4APoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter
- T45.AX5AAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
- T46.0X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
- T46.0X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
- T46.0X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
- T46.0X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
- T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.1X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
- T46.1X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
- T46.1X3APoisoning by calcium-channel blockers, assault, initial encounter
- T46.1X4APoisoning by calcium-channel blockers, undetermined, initial encounter
- T46.1X5AAdverse effect of calcium-channel blockers, initial encounter
- T46.2X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
- T46.2X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
- T46.2X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
- T46.2X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
- T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounter
- T46.3X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
- T46.3X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
- T46.3X3APoisoning by coronary vasodilators, assault, initial encounter
- T46.3X4APoisoning by coronary vasodilators, undetermined, initial encounter
- T46.3X5AAdverse effect of coronary vasodilators, initial encounter
- T46.4X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
- T46.4X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
- T46.4X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
- T46.4X4APoisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
- T46.4X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
- T46.5X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
- T46.5X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
- T46.5X3APoisoning by other antihypertensive drugs, assault, initial encounter
- T46.5X4APoisoning by other antihypertensive drugs, undetermined, initial encounter
- T46.5X5AAdverse effect of other antihypertensive drugs, initial encounter
- T46.6X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
- T46.6X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
- T46.6X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
- T46.6X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
- T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
- T46.7X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
- T46.7X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
- T46.7X3APoisoning by peripheral vasodilators, assault, initial encounter
- T46.7X4APoisoning by peripheral vasodilators, undetermined, initial encounter
- T46.7X5AAdverse effect of peripheral vasodilators, initial encounter
- T46.8X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
- T46.8X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
- T46.8X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
- T46.8X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
- T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
- T46.901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
- T46.902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
- T46.903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
- T46.904APoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
- T46.905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
- T46.992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
- T46.993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
- T46.994APoisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
- T46.995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
- T47.0X1APoisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
- T47.0X2APoisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
- T47.0X3APoisoning by histamine H2-receptor blockers, assault, initial encounter
- T47.0X4APoisoning by histamine H2-receptor blockers, undetermined, initial encounter
- T47.0X5AAdverse effect of histamine H2-receptor blockers, initial encounter
- T47.1X1APoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
- T47.1X2APoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
- T47.1X3APoisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
- T47.1X4APoisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
- T47.1X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
- T47.2X1APoisoning by stimulant laxatives, accidental (unintentional), initial encounter
- T47.2X2APoisoning by stimulant laxatives, intentional self-harm, initial encounter
- T47.2X3APoisoning by stimulant laxatives, assault, initial encounter
- T47.2X4APoisoning by stimulant laxatives, undetermined, initial encounter
- T47.2X5AAdverse effect of stimulant laxatives, initial encounter
- T47.3X1APoisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
- T47.3X2APoisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
- T47.3X3APoisoning by saline and osmotic laxatives, assault, initial encounter
- T47.3X4APoisoning by saline and osmotic laxatives, undetermined, initial encounter
- T47.3X5AAdverse effect of saline and osmotic laxatives, initial encounter
- T47.4X1APoisoning by other laxatives, accidental (unintentional), initial encounter
- T47.4X2APoisoning by other laxatives, intentional self-harm, initial encounter
- T47.4X3APoisoning by other laxatives, assault, initial encounter
- T47.4X4APoisoning by other laxatives, undetermined, initial encounter
- T47.4X5AAdverse effect of other laxatives, initial encounter
- T47.5X1APoisoning by digestants, accidental (unintentional), initial encounter
- T47.5X2APoisoning by digestants, intentional self-harm, initial encounter
- T47.5X3APoisoning by digestants, assault, initial encounter
- T47.5X4APoisoning by digestants, undetermined, initial encounter
- T47.5X5AAdverse effect of digestants, initial encounter
- T47.6X1APoisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
- T47.6X2APoisoning by antidiarrheal drugs, intentional self-harm, initial encounter
- T47.6X3APoisoning by antidiarrheal drugs, assault, initial encounter
- T47.6X4APoisoning by antidiarrheal drugs, undetermined, initial encounter
- T47.6X5AAdverse effect of antidiarrheal drugs, initial encounter
- T47.7X1APoisoning by emetics, accidental (unintentional), initial encounter
- T47.7X2APoisoning by emetics, intentional self-harm, initial encounter
- T47.7X3APoisoning by emetics, assault, initial encounter
- T47.7X4APoisoning by emetics, undetermined, initial encounter
- T47.7X5AAdverse effect of emetics, initial encounter
- T47.8X1APoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
- T47.8X2APoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
- T47.8X3APoisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
- T47.8X4APoisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
- T47.8X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
- T47.91XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
- T47.92XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
- T47.93XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
- T47.94XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
- T47.95XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
- T48.0X1APoisoning by oxytocic drugs, accidental (unintentional), initial encounter
- T48.0X2APoisoning by oxytocic drugs, intentional self-harm, initial encounter
- T48.0X3APoisoning by oxytocic drugs, assault, initial encounter
- T48.0X4APoisoning by oxytocic drugs, undetermined, initial encounter
- T48.0X5AAdverse effect of oxytocic drugs, initial encounter
- T48.1X1APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter
- T48.1X2APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter
- T48.1X3APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter
- T48.1X4APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter
- T48.1X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
- T48.201APoisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter
- T48.202APoisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter
- T48.203APoisoning by unspecified drugs acting on muscles, assault, initial encounter
- T48.204APoisoning by unspecified drugs acting on muscles, undetermined, initial encounter
- T48.205AAdverse effect of unspecified drugs acting on muscles, initial encounter
- T48.291APoisoning by other drugs acting on muscles, accidental (unintentional), initial encounter
- T48.292APoisoning by other drugs acting on muscles, intentional self-harm, initial encounter
- T48.293APoisoning by other drugs acting on muscles, assault, initial encounter
- T48.294APoisoning by other drugs acting on muscles, undetermined, initial encounter
- T48.295AAdverse effect of other drugs acting on muscles, initial encounter
- T48.3X1APoisoning by antitussives, accidental (unintentional), initial encounter
- T48.3X2APoisoning by antitussives, intentional self-harm, initial encounter
- T48.3X3APoisoning by antitussives, assault, initial encounter
- T48.3X4APoisoning by antitussives, undetermined, initial encounter
- T48.3X5AAdverse effect of antitussives, initial encounter
- T48.4X1APoisoning by expectorants, accidental (unintentional), initial encounter
- T48.4X2APoisoning by expectorants, intentional self-harm, initial encounter
- T48.4X3APoisoning by expectorants, assault, initial encounter
- T48.4X4APoisoning by expectorants, undetermined, initial encounter
- T48.4X5AAdverse effect of expectorants, initial encounter
- T48.5X1APoisoning by other anti-common-cold drugs, accidental (unintentional), initial encounter
- T48.5X2APoisoning by other anti-common-cold drugs, intentional self-harm, initial encounter
- T48.5X3APoisoning by other anti-common-cold drugs, assault, initial encounter
- T48.5X4APoisoning by other anti-common-cold drugs, undetermined, initial encounter
- T48.5X5AAdverse effect of other anti-common-cold drugs, initial encounter
- T48.6X1APoisoning by antiasthmatics, accidental (unintentional), initial encounter
- T48.6X2APoisoning by antiasthmatics, intentional self-harm, initial encounter
- T48.6X3APoisoning by antiasthmatics, assault, initial encounter
- T48.6X4APoisoning by antiasthmatics, undetermined, initial encounter
- T48.6X5AAdverse effect of antiasthmatics, initial encounter
- T48.901APoisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
- T48.902APoisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter
- T48.903APoisoning by unspecified agents primarily acting on the respiratory system, assault, initial encounter
- T48.904APoisoning by unspecified agents primarily acting on the respiratory system, undetermined, initial encounter
- T48.905AAdverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
- T48.991APoisoning by other agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
- T48.992APoisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter
- T48.993APoisoning by other agents primarily acting on the respiratory system, assault, initial encounter
- T48.994APoisoning by other agents primarily acting on the respiratory system, undetermined, initial encounter
- T48.995AAdverse effect of other agents primarily acting on the respiratory system, initial encounter
- T49.0X1APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter
- T49.0X2APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter
- T49.0X3APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter
- T49.0X4APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter
- T49.0X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.1X1APoisoning by antipruritics, accidental (unintentional), initial encounter
- T49.1X2APoisoning by antipruritics, intentional self-harm, initial encounter
- T49.1X3APoisoning by antipruritics, assault, initial encounter
- T49.1X4APoisoning by antipruritics, undetermined, initial encounter
- T49.1X5AAdverse effect of antipruritics, initial encounter
- T49.2X1APoisoning by local astringents and local detergents, accidental (unintentional), initial encounter
- T49.2X2APoisoning by local astringents and local detergents, intentional self-harm, initial encounter
- T49.2X3APoisoning by local astringents and local detergents, assault, initial encounter
- T49.2X4APoisoning by local astringents and local detergents, undetermined, initial encounter
- T49.2X5AAdverse effect of local astringents and local detergents, initial encounter
- T49.3X1APoisoning by emollients, demulcents and protectants, accidental (unintentional), initial encounter
- T49.3X2APoisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter
- T49.3X3APoisoning by emollients, demulcents and protectants, assault, initial encounter
- T49.3X4APoisoning by emollients, demulcents and protectants, undetermined, initial encounter
- T49.3X5AAdverse effect of emollients, demulcents and protectants, initial encounter
- T49.4X1APoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), initial encounter
- T49.4X2APoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, initial encounter
- T49.4X3APoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, initial encounter
- T49.4X4APoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, initial encounter
- T49.4X5AAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.5X1APoisoning by ophthalmological drugs and preparations, accidental (unintentional), initial encounter
- T49.5X2APoisoning by ophthalmological drugs and preparations, intentional self-harm, initial encounter
- T49.5X3APoisoning by ophthalmological drugs and preparations, assault, initial encounter
- T49.5X4APoisoning by ophthalmological drugs and preparations, undetermined, initial encounter
- T49.5X5AAdverse effect of ophthalmological drugs and preparations, initial encounter
- T49.6X1APoisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), initial encounter
- T49.6X2APoisoning by otorhinolaryngological drugs and preparations, intentional self-harm, initial encounter
- T49.6X3APoisoning by otorhinolaryngological drugs and preparations, assault, initial encounter
- T49.6X4APoisoning by otorhinolaryngological drugs and preparations, undetermined, initial encounter
- T49.6X5AAdverse effect of otorhinolaryngological drugs and preparations, initial encounter
- T49.7X1APoisoning by dental drugs, topically applied, accidental (unintentional), initial encounter
- T49.7X2APoisoning by dental drugs, topically applied, intentional self-harm, initial encounter
- T49.7X3APoisoning by dental drugs, topically applied, assault, initial encounter
- T49.7X4APoisoning by dental drugs, topically applied, undetermined, initial encounter
- T49.7X5AAdverse effect of dental drugs, topically applied, initial encounter
- T49.8X1APoisoning by other topical agents, accidental (unintentional), initial encounter
- T49.8X2APoisoning by other topical agents, intentional self-harm, initial encounter
- T49.8X3APoisoning by other topical agents, assault, initial encounter
- T49.8X4APoisoning by other topical agents, undetermined, initial encounter
- T49.8X5AAdverse effect of other topical agents, initial encounter
- T49.91XAPoisoning by unspecified topical agent, accidental (unintentional), initial encounter
- T49.92XAPoisoning by unspecified topical agent, intentional self-harm, initial encounter
- T49.93XAPoisoning by unspecified topical agent, assault, initial encounter
- T49.94XAPoisoning by unspecified topical agent, undetermined, initial encounter
- T49.95XAAdverse effect of unspecified topical agent, initial encounter
- T50.0X1APoisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
- T50.0X2APoisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
- T50.0X3APoisoning by mineralocorticoids and their antagonists, assault, initial encounter
- T50.0X4APoisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
- T50.0X5AAdverse effect of mineralocorticoids and their antagonists, initial encounter
- T50.1X1APoisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter
- T50.1X2APoisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter
- T50.1X3APoisoning by loop [high-ceiling] diuretics, assault, initial encounter
- T50.1X4APoisoning by loop [high-ceiling] diuretics, undetermined, initial encounter
- T50.1X5AAdverse effect of loop [high-ceiling] diuretics, initial encounter
- T50.2X1APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter
- T50.2X2APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter
- T50.2X3APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter
- T50.2X4APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter
- T50.2X5AAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.3X1APoisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter
- T50.3X2APoisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter
- T50.3X3APoisoning by electrolytic, caloric and water-balance agents, assault, initial encounter
- T50.3X4APoisoning by electrolytic, caloric and water-balance agents, undetermined, initial encounter
- T50.3X5AAdverse effect of electrolytic, caloric and water-balance agents, initial encounter
- T50.4X1APoisoning by drugs affecting uric acid metabolism, accidental (unintentional), initial encounter
- T50.4X2APoisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter
- T50.4X3APoisoning by drugs affecting uric acid metabolism, assault, initial encounter
- T50.4X4APoisoning by drugs affecting uric acid metabolism, undetermined, initial encounter
- T50.4X5AAdverse effect of drugs affecting uric acid metabolism, initial encounter
- T50.5X1APoisoning by appetite depressants, accidental (unintentional), initial encounter
- T50.5X2APoisoning by appetite depressants, intentional self-harm, initial encounter
- T50.5X3APoisoning by appetite depressants, assault, initial encounter
- T50.5X4APoisoning by appetite depressants, undetermined, initial encounter
- T50.5X5AAdverse effect of appetite depressants, initial encounter
- T50.6X1APoisoning by antidotes and chelating agents, accidental (unintentional), initial encounter
- T50.6X2APoisoning by antidotes and chelating agents, intentional self-harm, initial encounter
- T50.6X3APoisoning by antidotes and chelating agents, assault, initial encounter
- T50.6X4APoisoning by antidotes and chelating agents, undetermined, initial encounter
- T50.6X5AAdverse effect of antidotes and chelating agents, initial encounter
- T50.7X1APoisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter
- T50.7X2APoisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter
- T50.7X3APoisoning by analeptics and opioid receptor antagonists, assault, initial encounter
- T50.7X4APoisoning by analeptics and opioid receptor antagonists, undetermined, initial encounter
- T50.7X5AAdverse effect of analeptics and opioid receptor antagonists, initial encounter
- T50.8X1APoisoning by diagnostic agents, accidental (unintentional), initial encounter
- T50.8X2APoisoning by diagnostic agents, intentional self-harm, initial encounter
- T50.8X3APoisoning by diagnostic agents, assault, initial encounter
- T50.8X4APoisoning by diagnostic agents, undetermined, initial encounter
- T50.8X5AAdverse effect of diagnostic agents, initial encounter
- T50.901APoisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
- T50.902APoisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
- T50.903APoisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
- T50.904APoisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
- T50.905AAdverse effect of unspecified drugs, medicaments and biological substances, initial encounter
- T50.911APoisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
- T50.912APoisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
- T50.913APoisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
- T50.914APoisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
- T50.915AAdverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
- T50.991APoisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter
- T50.992APoisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter
- T50.993APoisoning by other drugs, medicaments and biological substances, assault, initial encounter
- T50.994APoisoning by other drugs, medicaments and biological substances, undetermined, initial encounter
- T50.995AAdverse effect of other drugs, medicaments and biological substances, initial encounter
- T50.A11APoisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), initial encounter
- T50.A12APoisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter
- T50.A13APoisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter
- T50.A14APoisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, initial encounter
- T50.A15AAdverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
- T50.A21APoisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), initial encounter
- T50.A22APoisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, initial encounter
- T50.A23APoisoning by mixed bacterial vaccines without a pertussis component, assault, initial encounter
- T50.A24APoisoning by mixed bacterial vaccines without a pertussis component, undetermined, initial encounter
- T50.A25AAdverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
- T50.A91APoisoning by other bacterial vaccines, accidental (unintentional), initial encounter
- T50.A92APoisoning by other bacterial vaccines, intentional self-harm, initial encounter
- T50.A93APoisoning by other bacterial vaccines, assault, initial encounter
- T50.A94APoisoning by other bacterial vaccines, undetermined, initial encounter
- T50.A95AAdverse effect of other bacterial vaccines, initial encounter
- T50.B11APoisoning by smallpox vaccines, accidental (unintentional), initial encounter
- T50.B12APoisoning by smallpox vaccines, intentional self-harm, initial encounter
- T50.B13APoisoning by smallpox vaccines, assault, initial encounter
- T50.B14APoisoning by smallpox vaccines, undetermined, initial encounter
- T50.B15AAdverse effect of smallpox vaccines, initial encounter
- T50.B91APoisoning by other viral vaccines, accidental (unintentional), initial encounter
- T50.B92APoisoning by other viral vaccines, intentional self-harm, initial encounter
- T50.B93APoisoning by other viral vaccines, assault, initial encounter
- T50.B94APoisoning by other viral vaccines, undetermined, initial encounter
- T50.B95AAdverse effect of other viral vaccines, initial encounter
- T50.Z11APoisoning by immunoglobulin, accidental (unintentional), initial encounter
- T50.Z12APoisoning by immunoglobulin, intentional self-harm, initial encounter
- T50.Z13APoisoning by immunoglobulin, assault, initial encounter
- T50.Z14APoisoning by immunoglobulin, undetermined, initial encounter
- T50.Z15AAdverse effect of immunoglobulin, initial encounter
- T50.Z91APoisoning by other vaccines and biological substances, accidental (unintentional), initial encounter
- T50.Z92APoisoning by other vaccines and biological substances, intentional self-harm, initial encounter
- T50.Z93APoisoning by other vaccines and biological substances, assault, initial encounter
- T50.Z94APoisoning by other vaccines and biological substances, undetermined, initial encounter
- T50.Z95AAdverse effect of other vaccines and biological substances, initial encounter
- T51.0X1AToxic effect of ethanol, accidental (unintentional), initial encounter
- T51.0X2AToxic effect of ethanol, intentional self-harm, initial encounter
- T51.0X3AToxic effect of ethanol, assault, initial encounter
- T51.0X4AToxic effect of ethanol, undetermined, initial encounter
- T51.1X1AToxic effect of methanol, accidental (unintentional), initial encounter
- T51.1X2AToxic effect of methanol, intentional self-harm, initial encounter
- T51.1X3AToxic effect of methanol, assault, initial encounter
- T51.1X4AToxic effect of methanol, undetermined, initial encounter
- T51.2X1AToxic effect of 2-Propanol, accidental (unintentional), initial encounter
- T51.2X2AToxic effect of 2-Propanol, intentional self-harm, initial encounter
- T51.2X3AToxic effect of 2-Propanol, assault, initial encounter
- T51.2X4AToxic effect of 2-Propanol, undetermined, initial encounter
- T51.3X1AToxic effect of fusel oil, accidental (unintentional), initial encounter
- T51.3X2AToxic effect of fusel oil, intentional self-harm, initial encounter
- T51.3X3AToxic effect of fusel oil, assault, initial encounter
- T51.3X4AToxic effect of fusel oil, undetermined, initial encounter
- T51.8X1AToxic effect of other alcohols, accidental (unintentional), initial encounter
- T51.8X2AToxic effect of other alcohols, intentional self-harm, initial encounter
- T51.8X3AToxic effect of other alcohols, assault, initial encounter
- T51.8X4AToxic effect of other alcohols, undetermined, initial encounter
- T51.91XAToxic effect of unspecified alcohol, accidental (unintentional), initial encounter
- T51.92XAToxic effect of unspecified alcohol, intentional self-harm, initial encounter
- T51.93XAToxic effect of unspecified alcohol, assault, initial encounter
- T51.94XAToxic effect of unspecified alcohol, undetermined, initial encounter
- T52.0X1AToxic effect of petroleum products, accidental (unintentional), initial encounter
- T52.0X2AToxic effect of petroleum products, intentional self-harm, initial encounter
- T52.0X3AToxic effect of petroleum products, assault, initial encounter
- T52.0X4AToxic effect of petroleum products, undetermined, initial encounter
- T52.1X1AToxic effect of benzene, accidental (unintentional), initial encounter
- T52.1X2AToxic effect of benzene, intentional self-harm, initial encounter
- T52.1X3AToxic effect of benzene, assault, initial encounter
- T52.1X4AToxic effect of benzene, undetermined, initial encounter
- T52.2X1AToxic effect of homologues of benzene, accidental (unintentional), initial encounter
- T52.2X2AToxic effect of homologues of benzene, intentional self-harm, initial encounter
- T52.2X3AToxic effect of homologues of benzene, assault, initial encounter
- T52.2X4AToxic effect of homologues of benzene, undetermined, initial encounter
- T52.3X1AToxic effect of glycols, accidental (unintentional), initial encounter
- T52.3X2AToxic effect of glycols, intentional self-harm, initial encounter
- T52.3X3AToxic effect of glycols, assault, initial encounter
- T52.3X4AToxic effect of glycols, undetermined, initial encounter
- T52.4X1AToxic effect of ketones, accidental (unintentional), initial encounter
- T52.4X2AToxic effect of ketones, intentional self-harm, initial encounter
- T52.4X3AToxic effect of ketones, assault, initial encounter
- T52.4X4AToxic effect of ketones, undetermined, initial encounter
- T52.811AToxic effect of alkenes, accidental (unintentional), initial encounter
- T52.812AToxic effect of alkenes, intentional self-harm, initial encounter
- T52.813AToxic effect of alkenes, assault, initial encounter
- T52.814AToxic effect of alkenes, undetermined, initial encounter
- T52.821AToxic effect of cycloparaffins, accidental (unintentional), initial encounter
- T52.822AToxic effect of cycloparaffins, intentional self-harm, initial encounter
- T52.823AToxic effect of cycloparaffins, assault, initial encounter
- T52.824AToxic effect of cycloparaffins, undetermined, initial encounter
- T52.891AToxic effect of other organic solvents, accidental (unintentional), initial encounter
- T52.892AToxic effect of other organic solvents, intentional self-harm, initial encounter
- T52.893AToxic effect of other organic solvents, assault, initial encounter
- T52.894AToxic effect of other organic solvents, undetermined, initial encounter
- T52.91XAToxic effect of unspecified organic solvent, accidental (unintentional), initial encounter
- T52.92XAToxic effect of unspecified organic solvent, intentional self-harm, initial encounter
- T52.93XAToxic effect of unspecified organic solvent, assault, initial encounter
- T52.94XAToxic effect of unspecified organic solvent, undetermined, initial encounter
- T53.0X1AToxic effect of carbon tetrachloride, accidental (unintentional), initial encounter
- T53.0X2AToxic effect of carbon tetrachloride, intentional self-harm, initial encounter
- T53.0X3AToxic effect of carbon tetrachloride, assault, initial encounter
- T53.0X4AToxic effect of carbon tetrachloride, undetermined, initial encounter
- T53.1X1AToxic effect of chloroform, accidental (unintentional), initial encounter
Showing the first 1,000 of 1,499 codes. Use search to find a specific code.